Skip to main content

Peer Review reports

From: Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis

Original Submission
3 Apr 2023 Submitted Original manuscript
29 Jul 2023 Reviewed Reviewer Report
11 Aug 2023 Reviewed Reviewer Report - Joeri de Hoog
30 Aug 2023 Author responded Author comments - Liang Wang
Resubmission - Version 2
30 Aug 2023 Submitted Manuscript version 2
31 Aug 2023 Author responded Author comments - Liang Wang
Resubmission - Version 3
31 Aug 2023 Submitted Manuscript version 3
9 Nov 2023 Reviewed Reviewer Report
14 Nov 2023 Reviewed Reviewer Report - Joeri de Hoog
15 Nov 2023 Author responded Author comments - Liang Wang
Resubmission - Version 4
15 Nov 2023 Submitted Manuscript version 4
Publishing
16 Nov 2023 Editorially accepted
22 Nov 2023 Article published 10.1186/s12886-023-03226-3

You can find further information about peer review here.

Back to article page